However, these new emergent dual agonists need further investigation to understand the mechanisms of action, how to interact with the respective receptors, increase efficacy, and good safety profile [90,91,92,93,94]
Since then, more than ten types of GLP-1 receptor agonists have received FDA approval and been brought to market, and with each new version, their effectiveness has increased
They improve blood glucose control by stimulating insulin secretion, reducing glucagon release, slowing gastric emptying, and increasing feelings of fullness
7, 2026, by BMJ , dont surprise Meghan Salamon, a dietitian at the Weight Center at Harvard-affiliated Massachusetts General Hospital